• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TIMP-1对人基质金属蛋白酶-1(基质溶解素-1)的抑制机制。

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.

作者信息

Gomis-Rüth F X, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov G P, Bartunik H, Bode W

机构信息

Max-Planck-Institut für Biochemie, Abteilung für Strukturforschung, Martinsried, Germany.

出版信息

Nature. 1997 Sep 4;389(6646):77-81. doi: 10.1038/37995.

DOI:10.1038/37995
PMID:9288970
Abstract

Matrix metalloproteinases (MMPs) are zinc endopeptidases that are required for the degradation of extracellular matrix components during normal embryo development, morphogenesis and tissue remodelling. Their proteolytic activities are precisely regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs). Disruption of this balance results in diseases such as arthritis, atherosclerosis, tumour growth and metastasis. Here we report the crystal structure of an MMP-TIMP complex formed between the catalytic domain of human stromelysin-1 (MMP-3) and human TIMP-1. TIMP-1, a 184-residue protein, has the shape of an elongated, contiguous wedge. With its long edge, consisting of five different chain regions, it occupies the entire length of the active-site cleft of MMP-3. The central disulphide-linked segments Cys 1-Thr 2-Cys 3-Val 4 and Ser 68-Val 69 bind to either side of the catalytic zinc. Cys 1 bidentally coordinates this zinc, and the Thr-2 side chain extends into the large specificity pocket of MMP-3. This unusual architecture of the interface between MMP-3 and TIMP-1 suggests new possibilities for designing TIMP variants and synthetic MMP inhibitors with potential therapeutic applications.

摘要

基质金属蛋白酶(MMPs)是锌内肽酶,在正常胚胎发育、形态发生和组织重塑过程中,细胞外基质成分的降解需要它们。其蛋白水解活性受到金属蛋白酶组织抑制剂(TIMPs)的精确调控。这种平衡的破坏会导致诸如关节炎、动脉粥样硬化、肿瘤生长和转移等疾病。在此,我们报道了人基质溶解素-1(MMP-3)的催化结构域与人类TIMP-1之间形成的MMP-TIMP复合物的晶体结构。TIMP-1是一种由184个残基组成的蛋白质,呈细长连续楔形。它的长边由五个不同的链区域组成,占据了MMP-3活性位点裂隙的全长。中央二硫键连接的片段Cys 1-Thr 2-Cys 3-Val 4和Ser 68-Val 69与催化锌的两侧结合。Cys 1与该锌意外配位,Thr-2侧链延伸至MMP-3的大特异性口袋中。MMP-3与TIMP-1之间这种不同寻常的界面结构为设计具有潜在治疗应用的TIMP变体和合成MMP抑制剂提供了新的可能性。

相似文献

1
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.TIMP-1对人基质金属蛋白酶-1(基质溶解素-1)的抑制机制。
Nature. 1997 Sep 4;389(6646):77-81. doi: 10.1038/37995.
2
Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.膜型1-基质金属蛋白酶与金属蛋白酶组织抑制剂-2(可溶性前胶原酶A受体)形成的复合物的晶体结构。
EMBO J. 1998 Sep 1;17(17):5238-48. doi: 10.1093/emboj/17.17.5238.
3
X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.与非肽类抑制剂复合的人基质溶素催化结构域的X射线结构:对抑制剂选择性的影响
Protein Sci. 1999 Jul;8(7):1455-62. doi: 10.1110/ps.8.7.1455.
4
Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.基质金属蛋白酶组织抑制因子(TIMP)结合的灵活性和可变性:胶原酶-3/MMP-13与TIMP-2复合物的X射线结构
J Mol Biol. 2007 Mar 2;366(4):1222-31. doi: 10.1016/j.jmb.2006.11.072. Epub 2006 Dec 1.
5
Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.人巨噬细胞弹性蛋白酶(基质金属蛋白酶-12)与异羟肟酸抑制剂复合物的晶体结构
J Mol Biol. 2001 Sep 28;312(4):743-51. doi: 10.1006/jmbi.2001.4953.
6
Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.基质金属蛋白酶及其生理抑制剂——金属蛋白酶组织抑制剂的结构基础。
Biol Chem. 2003 Jun;384(6):863-72. doi: 10.1515/BC.2003.097.
7
Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.基于1.1埃晶体结构的人巨噬细胞弹性蛋白酶(基质金属蛋白酶-12)的底物特异性决定因素
J Mol Biol. 2001 Sep 28;312(4):731-42. doi: 10.1006/jmbi.2001.4954.
8
Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples.用于检测生物样品中活性基质金属蛋白酶的金属蛋白酶抑制剂连接树脂的设计与表征
Chem Biol. 2006 Apr;13(4):379-86. doi: 10.1016/j.chembiol.2006.01.012.
9
Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.基于磷酰胺的异羟肟酸作为基质金属蛋白酶抑制剂的设计与合成
J Med Chem. 1999 Jan 14;42(1):87-94. doi: 10.1021/jm980142s.
10
Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.基质溶素催化结构域在2.0埃分辨率下的晶体结构:抑制剂诱导的构象变化
J Mol Biol. 1999 Oct 29;293(3):545-57. doi: 10.1006/jmbi.1999.3147.

引用本文的文献

1
Apigenin Attenuates Hepatic Ischemia-Reperfusion-Induced Lung Injury via Downregulation of MMP-3 and MCP-1: An Experimental Study in Rats.芹菜素通过下调基质金属蛋白酶-3和单核细胞趋化蛋白-1减轻肝缺血再灌注诱导的肺损伤:大鼠实验研究
J Clin Med. 2025 May 18;14(10):3530. doi: 10.3390/jcm14103530.
2
Directed evolution of metalloproteinase inhibitor TIMP-1 for selective inhibition of MMP-9 exploits catalytic and fibronectin domain interactions.金属蛋白酶抑制剂TIMP-1的定向进化用于选择性抑制MMP-9,利用了催化结构域和纤连蛋白结构域之间的相互作用。
J Biol Chem. 2025 May 21;301(6):110258. doi: 10.1016/j.jbc.2025.110258.
3
Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63.
金属蛋白酶抑制剂和细胞因子TIMP-1的N-糖基化程度通过CD63决定胰腺癌细胞的增殖和存活。
J Biol Chem. 2025 May 8;301(6):110211. doi: 10.1016/j.jbc.2025.110211.
4
Parallel Networks to Predict TIMP and Protease Cell Activity of Nucleus Pulposus Cells Exposed and Not Exposed to Pro-Inflammatory Cytokines.用于预测暴露和未暴露于促炎细胞因子的髓核细胞中组织金属蛋白酶抑制剂(TIMP)和蛋白酶细胞活性的并行网络
JOR Spine. 2025 Feb 20;8(1):e70051. doi: 10.1002/jsp2.70051. eCollection 2025 Mar.
5
MMP-3 and TIMP-1 as prognostic biomarkers in VZV-induced retinal necrosis.基质金属蛋白酶-3和金属蛋白酶组织抑制因子-1作为水痘-带状疱疹病毒诱导的视网膜坏死的预后生物标志物
Front Cell Infect Microbiol. 2024 Dec 12;14:1502912. doi: 10.3389/fcimb.2024.1502912. eCollection 2024.
6
Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials.细胞外基质作为黑色素瘤治疗的靶点:从假设到临床试验。
Cells. 2024 Nov 19;13(22):1917. doi: 10.3390/cells13221917.
7
The Role of Biomarkers in Predicting Outcomes of Anterior Cruciate Ligament Reconstruction: A Systematic Review.生物标志物在预测前交叉韧带重建结果中的作用:一项系统评价。
Orthop J Sports Med. 2024 Oct 7;12(10):23259671241275072. doi: 10.1177/23259671241275072. eCollection 2024 Oct.
8
The Effect of Tissue Inhibitor of Metalloproteinases on Scar Formation after Spinal Cord Injury.组织金属蛋白酶抑制剂对脊髓损伤后瘢痕形成的影响。
Cells. 2024 Sep 14;13(18):1547. doi: 10.3390/cells13181547.
9
A Novel Strategy for the Treatment of Aneurysms: Inhibition of MMP-9 Activity through the Delivery of TIMP-1 Encoding Synthetic mRNA into Arteries.一种治疗动脉瘤的新策略:通过将 TIMP-1 编码的合成 mRNA 递送至动脉来抑制 MMP-9 活性。
Int J Mol Sci. 2024 Jun 15;25(12):6599. doi: 10.3390/ijms25126599.
10
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity.TIMP-1 是髓系树突状细胞中 MHC-I 表达的激活剂,对肿瘤免疫原性有影响。
Genes Immun. 2024 Jun;25(3):188-200. doi: 10.1038/s41435-024-00274-7. Epub 2024 May 22.